Delivery Order SPE2DB20D1004-SPE2DB25FNLCF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) valued at $2,912.46. This non-competitive, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly used to treat depression and...
- The Defense Logistics Agency awarded a delivery order valued at $1,507.57 to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly prescribed for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,819.74 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $4,884.40 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with completion required by September 9, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The U.S. Department of Defense, through its Medical Supply Chain organization, awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Escitalopram 10mg tablets in a quantity of 1,000 units. This firm fixed-price delivery order, valued at $3,103.26, represents a non-competitive set-aside award and is scheduled for completion by October 1, 2025. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 units) under a firm fixed-price contract valued at $1,740.43. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency awarded a $1,711.70 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,145.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with an ultimate completion date of September 11, 2025. This non-set-aside contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLCFDelivery Order
The Defense Logistics Agency awarded a $15,443.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, with a completion date of September 30, 2025. This non-set-aside competitive award was issued on September 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its broader role supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceuticals and medical supplies globally to support military healthcare programs. Escitalopram, a selective serotonin reuptake inhibitor antidepressant, represents a critical psychiatric medication within the Defense Health Agency's formulary for treating service members and military beneficiaries. The award demonstrates the contractor's continued capability to meet federal procurement requirements through open competition and deliver essential psychiatric medications efficiently to the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 9/29/25 |